|

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

RECRUITINGSponsored by Northwestern University
Actively Recruiting
SponsorNorthwestern University
Started2000-03
Est. completion2030-12
Eligibility
Age18 Years – 80 Years
SexFEMALE
Healthy vol.Accepted
Locations1 site

Summary

RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.

Eligibility

Age: 18 Years – 80 YearsSex: FEMALEHealthy volunteers accepted
DISEASE CHARACTERISTICS:

* Meets one of the following criteria:

  * Considered to be at increased risk for developing ovarian cancer, as defined by one of the following:

    * Has at least one first-degree relative (mother, sister, or daughter) with ovarian, primary peritoneal, or fallopian tube cancer
    * Has at least two first or second degree relatives diagnosed before age 50 with either ovarian, primary peritoneal, fallopian tube, and/or pancreatic cancer who have tested positive for hereditary cancer syndrome that includes an increased risk of gynecologic cancer (e.g., BRCA1/2 or Lynch Syndrome)or have increased risk as deemed by a certified genetic counselor
    * A personal or family history of a hereditary cancer syndrome that includes an increased risk of gynecologic cancer
    * Increased risk as deemed by a certified genetic counselor
  * Undergoing surgery for a gynecologic condition, including any of the following:

    * Diagnosis of a reproductive cancer
    * Benign gynecological condition (e.g., uterine leiomyomata, endometriosis, pelvic inflammatory disease, or follicular or corpus luteum ovarian cysts)
    * Highly suspicious adnexal mass
    * Risk-reducing prophylactic oophorectomy

PATIENT CHARACTERISTICS:

Age

* Between the ages of 18 and 80

Conditions11

Breast CancerCancerCervical CancerEndometrial CancerFallopian Tube CancerHereditary Breast/Ovarian Cancer (brca1, brca2)Ovarian CancerSarcomaUterine LeiomyomataVaginal Cancer

Locations1 site

Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, 60611-3013
Clinical Trials Office - Robert H. Lurie Comprehensive Cancer312-695-1301cancer@northwestern.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.